NAD+ Carnitine Blend Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about NAD+ Carnitine Blend dosing: protocols and safety.
Dose Range
NAD+ 50-250 mg plus L-carnitine 250-1000 mg per session (community / IV-clinic practice; not trial-validated). Start at the low end of both.
Frequency
1-3x per week, usually cycled (e.g. 4-8 week blocks with breaks).
Cycle Length
Commonly run in 4-8 week blocks with breaks in community practice. There is no evidence-based cycle length for the blend, and continuous long-term injectable use is unstudied.
Dosage Calculator
Calculate exact dosing for NAD+ Carnitine Blend.
Dosing Protocols
There is no clinically validated protocol for this blend. The ranges below reflect how the two components are dosed in community and IV-clinic practice, not a studied combination. Research use only (RUO).
Conservative starting approach (community practice):
- NAD+ component: 50-100 mg by slow subcutaneous or IM injection, 1-2x per week. NAD+ given quickly by injection or IV commonly causes chest tightness/pressure, flushing, and nausea - start low and inject slowly.
- L-Carnitine component: 250-500 mg IM/SubQ (or per product label), 1-3x per week.
Begin with a single low dose to assess tolerance - especially the NAD+ flushing/chest-pressure reaction - before increasing frequency. Note that oral L-carnitine (1-2 g/day) and oral NAD+ precursors are simpler and considerably better-studied than injection [PMID:12908852][PMID:29599478].
Community practice (not clinically validated; RUO):
- NAD+ component: 100-150 mg SubQ/IM, 2-3x per week, injected slowly to limit the flushing/chest-pressure reaction.
- L-Carnitine component: 500-1000 mg, up to 3x per week, often timed before training.
Run in cycles (e.g. 4-8 weeks) rather than continuously, and reassess tolerance and any perceived benefit. For reference, the oral L-carnitine RCT that showed recovery and soreness benefits used ~2 g/day of L-carnitine tartrate for 5 weeks [PMID:34684429].
Experienced community users (anecdotal; no trial basis; RUO):
- NAD+ component: up to ~150-250 mg per session, slow SubQ/IM, 2-3x per week - or as a slow IV drip in a clinical setting where flushing and chest pressure can be managed.
- L-Carnitine component: ~1000 mg, up to 3-4x per week.
Higher NAD+ doses sharply increase flushing, chest tightness, and nausea; slowing the administration is the main mitigation, not premedication. There is no evidence that higher or more frequent dosing improves outcomes, and there is no long-term safety data for the injected blend. More is not better here.
Side Effects & Safety
Contraindications
Not for use in pregnancy or breastfeeding. Avoid or use only under medical supervision with active cancer (NAD+ metabolism intersects pathways relevant to cell proliferation; data are mixed, so this is precautionary). Caution with seizure disorders. Severe kidney disease (L-carnitine is renally cleared and can accumulate, e.g. in dialysis patients) or severe liver disease. L-carnitine may blunt thyroid hormone action, which is relevant for people with hypothyroidism. Anyone on prescription medication or with cardiovascular disease should consult a clinician before use. RUO - not a medical treatment.
Frequently Asked Questions
What is the recommended NAD+ Carnitine Blend dosage?
The typical dose range for NAD+ Carnitine Blend is NAD+ 50-250 mg plus L-carnitine 250-1000 mg per session (community / IV-clinic practice; not trial-validated). Start at the low end of both.. It is usually administered 1-3x per week, usually cycled (e.g. 4-8 week blocks with breaks).. Always start with the lowest effective dose.
How often should I take NAD+ Carnitine Blend?
1-3x per week, usually cycled (e.g. 4-8 week blocks with breaks).
Does NAD+ Carnitine Blend need to be cycled?
Yes, typical cycle length is Commonly run in 4-8 week blocks with breaks in community practice. There is no evidence-based cycle length for the blend, and continuous long-term injectable use is unstudied..
What are NAD+ Carnitine Blend side effects?
NAD+ component: rapid injection or IV commonly causes transient chest tightness/pressure, flushing, warmth, nausea, lightheadedness, and cramping - these are dose- and speed-dependent and ease when the injection is slowed. Injection-site redness or soreness. L-Carnitine component: GI upset (nausea, cramps, diarrhea), and a fishy body odor at higher doses (from trimethylamine). General: injection-site reactions, plus the usual sterility and dosing risks of self-injected compounded products. No controlled safety data exist for the combined injectable blend.
Where can I buy NAD+ Carnitine Blend?
Visit our vendor directory to compare the vendors we track and their Trust Scores.
Free 2026 Peptide Cheat Sheet (PDF)
38 compounds and blends: vial sizes, BAC water volumes, dosing ranges and bloodwork markers.